- Pegfilgrastime2006 | Publication without faculty affiliation
- Lipeg/pegfilgrastim in practice2022 | Faculty of Medicine in Pilsen
- Supportive care: the role of pegfilgrastim in oncology2022 | Faculty of Medicine in Pilsen
- One injection is sufficient2019 | Faculty of Medicine in Pilsen
- OPERa Study2013 | First Faculty of Medicine
- New possibilities in the treatment of febrile neutropenia - comfortable home treatment in a single dose2020 | Faculty of Medicine in Pilsen
- A Case Report: Neutropenia Grade IV and Febrile Neutropenia in a Metastatic Breast Cancer Patient Treated With Palliative Chemotherapy Cyclophosphamide/Myocet2013 | Faculty of Medicine in Hradec Králové
- Febrile neutropenia - new notes on prophylaxis with growth factors of granulopoiesis2023 | Faculty of Medicine in Pilsen
- Pegfilgrastim support for full delivery of BEACOPP-14 chemotherapy for patients with high-risk Hodgkin's lymphoma: results of a phase II study2006 | First Faculty of Medicine
- Pegfilgrastim support for full delivery of BEACOPP-14 chemotherapy for patients with high-risk Hodgkin's lymphoma: results of a phase II study2006 | Faculty of Physical Education and Sport
- How safe are G-CSF biosimilars?2019 | Faculty of Medicine in Pilsen
- Risk of febrile neutropenia and its prophylaxis during chemotherapy for breast cancer2023 | Faculty of Medicine in Pilsen
- Pegfilgrastrim, lipegfilgrastim, febrile neutropenia, keeping chemotherapy dose intensity and COVID-19 in addition to it2020 | Faculty of Medicine in Pilsen
- Pegfilgrastim provides effective primary prophylaxis against febrile neutropenia in patients with NHL undergoing chemotherapy: Initial results from an integrated analysis – The Neulasta versus Current Neutropenia Management Practice (Neucup) ProjectPublication without faculty affiliation
- Lékový profil: Certolizumab2015 | Third Faculty of Medicine